Why is Jupiter Life Lin falling/rising?
As of 26-Jun, Jupiter Life Line Hospitals Ltd is currently priced at 1,446.45, reflecting a recent increase but underperforming against its moving averages and the broader market. Despite a strong one-year return, the stock faces challenges with declining delivery volume and a high PEG ratio, indicating potential overvaluation.
As of 26-Jun, Jupiter Life Line Hospitals Ltd is experiencing a price increase, currently at 1,446.45, reflecting a change of 21.1 or 1.48% upward. Today's price summary indicates that the stock has outperformed its sector by 0.71% and has gained after two consecutive days of decline. However, it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The stock's performance over the past week shows a decline of 4.21%, while it has increased by 1.98% over the past month. Despite a strong one-year return of 16.77%, the company has faced challenges, including a flat PAT in the latest quarter and a high PEG ratio of 2.3, indicating that while the stock has shown good historical performance, its current valuation may be perceived as expensive.In the broader market context, the Sensex has increased by 2.94% over the past week, contrasting with Jupiter Life Line's decline, which suggests that the stock is underperforming relative to the market. Year-to-date, the stock has decreased by 6.75%, while the benchmark has risen by 7.19%. The high institutional holdings at 25.67% may provide some support for the stock, as these investors typically have better resources for analyzing company fundamentals. However, the significant drop in delivery volume by 78.37% against the 5-day average indicates falling investor participation, which could further pressure the stock's price in the near term.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
